Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EARS

Auris Medical (EARS) Stock Price, News & Analysis

Auris Medical logo

About Auris Medical Stock (NASDAQ:EARS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$2.25
$3.27
52-Week Range
N/A
Volume
830,271 shs
Average Volume
3.10 million shs
Market Capitalization
$3.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EARS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Auris Medical and its competitors with MarketBeat's FREE daily newsletter.

EARS Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

EARS Stock Analysis - Frequently Asked Questions

Auris Medical Holding Ltd. (NASDAQ:EARS) announced its earnings results on Thursday, May, 11th. The biotechnology company reported ($4.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.80) by $1.60.

Auris Medical's stock reverse split before market open on Wednesday, May 1st 2019.The 1-20 reverse split was announced on Tuesday, April 30th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 30th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Auris Medical investors own include Helios and Matheson Analytics (HMNY), TransEnterix (TRXDW), Novavax (NVAX), OPKO Health (OPK), Anavex Life Sciences (AVXL), Flexion Therapeutics (FLXN) and Rigel Pharmaceuticals (RIGL).

Company Calendar

Last Earnings
5/11/2017
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EARS
CIK
1601936
Fax
N/A
Employees
132,200
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.83
Quick Ratio
3.83

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.57 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
11,417,000
Free Float
N/A
Market Cap
$3.43 million
Optionable
Not Optionable
Beta
1.17
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:EARS) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners